Advertisement

Biomaterial News: Breaking Biomaterial News, Comments and Articles.

23:07 EDT 24th May 2013 | BioPortfolio

Biomaterial News RSSTwitter

Read the latest Biomaterial News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Biomaterial.

Search or Follow Our Biomaterial News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Biomaterial News.
You can also follow our Biomaterial news stories on Twitter: @BiomaterialsBio

Showing "biomaterials biomaterial" News Articles 1 to 25 of 378

Thursday 23rd May 2013

Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing

ANN ARBOR, Mich., May 23, 2013 /PRNewswire-USNewswire/ -- Every day, their baby stopped breathing, his collapsed bronchus blocking the crucial flow of air to his lungs. April and Bryan Gionfriddo watched helplessly, just praying that somehow the dire predictions weren't true. "Quite a few doctors said he had a good chance of not leaving the hospital alive," says April Gionfriddo, about her n...

Wednesday 22nd May 2013

TheraCoat Has Completed a Capital Raising of $7M led by Pontifax and Chaim Hurvitz's CHealth Fund

TheraCoat Ltd. (TheraCoat), a clinical stage specialty pharmaceutical company focused on innovative drug-delivery solutions for the treatment of intra-cavital diseases, announces today the completion of a successful capital raise of $7M from private investors and venture Funds, both in Israel and abroad. Amongst the investors are Pontifax, and Chaim Hurvit...

Monday 20th May 2013

Aging Population and Material Advancements Boost Demand for Endodontic Supplies, According to New Report by Global Industry Analysts, Inc.

GIA announces the release of a comprehensive global report on Endodontic Supplies markets. Global market for Endodontic Supplies is projected to reach US$798 million by 2018, driven by growing utilization of dental care services among aging baby boomers and greater emphasis on maintaining dental health for aesthetic and functional reasons among young adults. San Jose, California (PRWEB) May 20, 20...

MiMedx Secures a $3.0 Million Revolving Line of Credit with Bank of America

KENNESAW, Ga., May 20, 2013 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that it has secured a revolving line of credit with Bank of America.  The revolving line of credit facility, which is secured by the Company's...

BioRestorative Therapies Signs Agreement with Dexterity, Inc. to Advance Production of the Company's Novel brtxDISC™ Stem Cell Therapy Device

JUPITER, Fla., May 20, 2013  /PRNewswire/ -- BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTC BB: BRTX), a life sciences company focused on developing stem cell based therapies for various personal applications, announces the signing of a consulting agreement with Dexterity, Inc. ("Dexterity"). Dexterity is a product design and bioengineering firm that will pro...

Sequent Medical, Inc. Launches New SL Family of WEB Aneurysm Embolization Devices

ALISO VIEJO, Calif., May 20, 2013 /PRNewswire/ -- Sequent Medical, Inc. announced today that it has received CE mark for the SL ("Single Layer") family of WEB® Aneurysm Embolization Devices, and has commenced a controlled release of these new models in select neurovascular centers in Europe.  The SL family offers a lower profile and superior navigability that will enable physicians to tr...

Wednesday 15th May 2013

Engineered Biomaterial Could Eliminate The Body's Negative Reaction To Medical Implants

It's a familiar scenario - a patient receives a medical implant and days later, the body attacks the artificial valve or device, causing complications to an already compromised system. Expensive, state-of-the-art medical devices and surgeries often a...

aap reports Q1 results with strong influence on full year: 48% EBITDA growth, 5% sales growth

aap Implantate AG / aap reports Q1 results with strong influence on full year: 48% EBITDA growth, 5% sales growth . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for the content of this announcement. aap Implantate AG reports EUR 10.4 million (previous year: EUR 9.9 million) in sales in the first three months of the financial year 2013, which amounts to year...

Five UTEST companies to tackle critical healthcare challenges

Program's second cohort includes eQOL, E-Twenty Development, Root2Crown, Treata Smart Solutions and TrendMD TORONTO, May 15, 2013 /PRNewswire/ - Five companies tackling pervasive healthcare challenges — such as assessing dental health, helping patients and medical personnel navigate hospitals with greater ease, staying current with medical literature, or creating digital tools to hel...

Monday 13th May 2013

Engineered biomaterial could improve success of medical implants

(University of Washington) Expensive, state-of-the-art medical devices and surgeries often are thwarted by the body's natural response to attack something in the tissue that appears foreign. Now, University of Washington engineers have demonstrated i...

Sunday 12th May 2013

Transplant Of Biomaterial Effective In Mice With Type 1 Diabetes

Researchers have made a significant first step with newly engineered biomaterials for cell transplantation that could help lead to a possible cure for Type 1 diabetes, which affects about 3 million Americans. Georgia Tech engineers and Emory Universi...

Friday 10th May 2013

Engineering a treatment for diabetes

Researchers have made a significant first step with newly engineered biomaterials for cell transplantation that could help lead to a possible cure for Type 1 diabetes, which affects about 3 million...

Secant Medical Receives MedTech Leadership Award from PACT at 20th Enterprise Awards

In a black-tie gala attended by more than 900 business leaders and companies in advanced technology, Secant Medical, Inc. received the MedTech Leadership Award at the 20th Annual Enterprise Awards. The company accepted the honor from the Greater Philadelphia Alliance for Capital and Technologies (PACT) during a ceremony at Valley Forge Casino Thursday even...

Thursday 9th May 2013

Newly engineered biomaterials could lead to possible cure for Type 1 diabetes, find researchers

Researchers have made a significant first step with newly engineered biomaterials for cell transplantation that could help lead to a possible cure for Type 1 diabetes, which affects about 3 million Americans.

Warsaw Mayor Hosts Keynote Speakers OrthoPediatrics Founder and ESPN Chief Medical Correspondent at OrthoTec 2013

WARSAW, Indiana, May 9, 2013 /PRNewswire/ -- More than 300 professionals from over 100 unique OEMs and manufacturers have pre-registered to attend this year's conference program, on June 5 - 6, 2013 at Grace College in Warsaw, IN. Employees at major orthopaedic OEMs are eligible for free registration at http://www.orthotecshow.com The Mayor of the City of Warsaw, Dr. Joe...

JPK reports on the applied research of Ioan Notingher at the University of Nottingham using AFM and the Tip Assisted Optics module to study individual nanotubes and fibrils.

JPK Instruments, a world-leading manufacturer of nanoanalytic instrumentation for research in life sciences and soft matter, reports on the research studies of Dr Ioan Notingher, associate professor in the faculty of science at the University of Nottingham. With a research interest in the development of new optical and spectroscopic methods for studying biomaterials, he is applying JPK's atomic f...

Wednesday 8th May 2013

Susan Lindquist, MIT to Keynote Present at 8th Protein Kinases Conference (July 8-9, 2013 in Boston)

Monrovia, CA, May 09, 2013 --(PR.com)-- Susan Lindquist, Professor of Biology and Member of Whitehead Institute at MIT, will give a keynote presentation on “Hsp90 as a Sensor for In Vivo Drug: Target Interactions” at the 8th Protein Kinases in Drug Discovery Conference on July 8-9, 2013 in Boston, MA. Heat shock proteins (Hsps) function as chaperones to promote the correct folding an...

Biomaterial shows promise for Type 1 diabetes treatment

Researchers have made a significant first step with newly engineered biomaterials for cell transplantation that could help lead to a possible cure for Type 1 diabetes, which affects about 3 million Americans. Georgia Institute of Technology (Georgia...

Monday 6th May 2013

FzioMed Receives Approval for Dynavisc® in Australia

FzioMed, a privately held medical device company based in San Luis Obispo, CA., is pleased to announce the inclusion of Dynavisc on the Australian Register of Therapeutic Goods (ARTG). Dynavisc is an absorbable, clear, viscoelastic gel that is applied to tendons and peripheral nerves to reduce fibrosis and the formation of adhesions following surgery....

Friday 3rd May 2013

Atrium Medical Announces 1-year results of the INFUSE-AMI Trial

HUDSON, N.H., May 3, 2013 /PRNewswire/ -- Atrium Medical Corporation, a business unit of MAQUET Cardiovascular, today announced the 1-year results of the INFUSE-AMI (Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction) trial. Dr. Gregg Stone, the principle investigator, presented the exciting findings at the 62nd Annual American College of Cardiology Confere...

Etex extends supply agreement with Knee Creations

Biomaterials company Etex has announced the renewal and long-term extension of its supply agreement with Knee Creations.

Thursday 2nd May 2013

ETEX Corporation announces extended Supply Agreement with Knee Creations, LLC

CAMBRIDGE, Mass., May 2, 2013 /PRNewswire/ -- ETEX Corporation, an advanced biomaterials company, today announced the renewal and long term extension of their Supply Agreement with Knee Creations, LLC. Knee Creations utilizes ETEX's proprietary nanocrystalline calcium phosphate technology in their novel Subchondroplasty® procedure. Brian Ennis, President and CEO of ETEX Corporation co...

Wednesday 1st May 2013

MiMedx Announces Record First Quarter 2013 Results

KENNESAW, Ga., May 1, 2013 /PRNewswire/ -- MiMedx Group, Inc. (NasdaqCM: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today its results for the quarter ended March 31, 2013. Highlights of First Quarter 2013 Results include: Revenue exceeded forecast for fifth consecutive...

Tuesday 30th April 2013

Freehold NJ Orthopedic Surgeon Dr. Alan Nasar Elected Chairman of the Department of Orthopedic Surgery at CentraState Medical Center

Freehold, NJ, May 01, 2013 --(PR.com)-- Advanced Orthopedic and Sports Medicine Institutes' Orthopedic Surgeon, Dr. Alan Nasar has been elected Chairman of the Department of Orthopedic Surgery at CentraState Medical Center. Dr. Nasar was elected by his peers to head the orthopedic department at one of New Jersey's premier hospitals; CentraState Medical Center. With his election, Dr. Nasa...

Friday 26th April 2013

Pharmaceutical Research: Nanoparticles in the Brain: A Potential Therapeutic System Targeted to an Early Defect Observed in Many Neurodegenerative Diseases

Type: Review PaperCurrently, there are no effective treatments or cures for many neurodegenerative diseases affecting an aging baby-boomer generation. The ongoing problem with many of the current therapeutic treatments is that most are aimed at disso...


Search BioPortfolio:
Advertisement

News Quicklinks

Advertisement